| Stage | DLTR | % of rev | RBA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.9B | 100.00% | $1.3B | 100.00% | DLTR ×3.71 |
| Gross profit | $2.1B | 42.91% | $575M | 43.63% | RBA +0.7pp |
| Operating income | $690M | 14.11% | $225M | 17.07% | RBA +3.0pp |
| Pre-tax income | $686M | 14.03% | $186M | 14.12% | RBA +0.1pp |
| Net income | $515M | 10.52% | $144M | 10.90% | RBA +0.4pp |
| Stage | DLTR | RBA | Gap · A − B |
|---|---|---|---|
| Revenue | $4.9B100.00% | $1.3B100.00% | DLTR ×3.71 |
| Gross profit | 42.91%$2.1B | 43.63%$575M | RBA +0.7pp |
| Operating income | 14.11%$690M | 17.07%$225M | RBA +3.0pp |
| Pre-tax income | 14.03%$686M | 14.12%$186M | RBA +0.1pp |
| Net income |
| 10.52%$515M |
| 10.90%$144M |
| RBA +0.4pp |
No disclosed counterparties: RBA.
None